跳至主要内容
临床试验/NCT01547156
NCT01547156已完成不适用

Mobile Sipoo a Randomized Controlled Trial

VTT Technical Research Centre of Finland1 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2011年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
56
试验地点
1
主要终点
Change in blood pressure

研究概览

简要总结

Mobile Sipoo is a randomized controlled trial aiming to improve selfcare and outcomes of diabetes and hypertensive patients by introducing a remote patient monitoring system supported with automatic patient decision support. The feedback system is coupled with back-office health coaching.

详细描述

Self-monitored data from blood pressure meters (SMBP), glucometers (SMBG), scales and pedometers are transferred by mobile phone terminals to a tethered personal health record (PHR) integrated with the provider EHR. The PHR application includes tools to display of self-monitoring data.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
30 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Confirmed diagnosis of diabetes or hypertension made at least 6 months prior to inclusion to study.
  • For hypertensive patients: Blood pressure over 140/90 mmHg (systolic and diastolic separately) treated or untreated
  • Diabetes patients: Glycohemoglobin A1c over 6.5% but lower that 11%
  • use of diabetes medication

排除标准

  • Patients who decline to participate
  • Patients specifically excluded by the health centre physician
  • Patients unable to co-operate, expected poor study compliance (IT illiterate) or reluctance to perform self monitoring
  • Pregnancy
  • Patients with a life expectance of less than one year
  • Patients with major elective surgery planned within 6 months or patient has had major surgery within last 2 months.
  • Patients with psychiatric disorders (depression), abuse of alcohol or narcotics complicating or disabling participation in the study

结局指标

主要结局

Change in blood pressure

时间窗: 9 months

Change in Hba1c(for diabetes patients)

时间窗: 9 months

次要结局

  • Achieving the desired target range(9 months)
  • Adverse effects(9 months)
  • Hypoglycemia(9 months)
  • Change in body weight(9 months)
  • Change in BMI(9 months)
  • Change in medication(9 months)
  • Change in FÍNSIK scores(9 months)

研究者

发起方
VTT Technical Research Centre of Finland
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验